New Research Article shows Beneficial Effects of a New Drug in Transgenic Mouse Model with Cognitive Dysfunctions and Anxiety Phenotype
https://www.damonapharma.com/wp-content/uploads/2021/01/Capture-wWebsite.jpg
613
472
Thomas Prevot
https://secure.gravatar.com/avatar/441964589afd9a17fb378ee0cd8d1fed?s=96&d=mm&r=g
The paper was published by Fee et al. in the International Journal of Neuropsychopharmacology. Patients suffering from mood and anxiety disorders often exhibit a deficit in brain inhibition. This deficit in brain inhibition is due do dysfunctional somatostatin (SST) cells, causing mood and cognitive symptoms in patients. Using transgenic mice in which the SST cell…
read more